Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Kaltenbach

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
JACC. Cardiovascular Interventions|February 25, 2012
Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosisEhrin J Armstrong, Dmitriy N Feldman, Tracy Y Wang, et al.
Circulation. Cardiovascular Interventions|April 25, 2019
Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for WomenJennifer A Rymer, Lisa A Kaltenbach, Ajar Kochar, et al.
Journal of Cardiac Failure|April 10, 2024
Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HFSatoshi Shoji, Lisa A Kaltenbach, Bradi B Granger, et al.
Circulation|June 12, 2013
Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)Dmitriy N Feldman, Rajesh V Swaminathan, Lisa A Kaltenbach, et al.
Journal of Cardiac Failure|July 29, 2022
The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HFVishal N Rao, Lisa A Kaltenbach, Bradi B Granger, et al.
JAMA|March 6, 2023
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical TrialNeha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, et al.
Journal of Cardiac Failure|April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF TrialBradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.
American Heart Journal|December 24, 2024
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinicsAdam J Nelson, Lisa A Kaltenbach, Darren K McGuire, et al.
Circulation|July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
American Journal of Preventive Cardiology|August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trialAdam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
JACC. Cardiovascular Interventions|February 25, 2012
Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosisEhrin J Armstrong, Dmitriy N Feldman, Tracy Y Wang, et al.
Circulation. Cardiovascular Interventions|April 25, 2019
Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for WomenJennifer A Rymer, Lisa A Kaltenbach, Ajar Kochar, et al.
Journal of Cardiac Failure|April 10, 2024
Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HFSatoshi Shoji, Lisa A Kaltenbach, Bradi B Granger, et al.
Circulation|June 12, 2013
Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)Dmitriy N Feldman, Rajesh V Swaminathan, Lisa A Kaltenbach, et al.
Journal of Cardiac Failure|July 29, 2022
The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HFVishal N Rao, Lisa A Kaltenbach, Bradi B Granger, et al.
JAMA|March 6, 2023
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical TrialNeha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, et al.
Journal of Cardiac Failure|April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF TrialBradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.
American Heart Journal|December 24, 2024
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinicsAdam J Nelson, Lisa A Kaltenbach, Darren K McGuire, et al.
Circulation|July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
American Journal of Preventive Cardiology|August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trialAdam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Pageof 7